What is antimicrobial stewardship, and how does it relate to safety and quality in medication use?

• A. A program to increase antibiotic use to prevent infections.
• B. Optimizes antibiotic use to improve patient outcomes and reduce resistance and adverse events; guided by protocols and surveillance.
• C. A policy to limit injections.
• D. A system for lab test ordering.

Answer: (B)

Antimicrobial stewardship is about optimizing how antibiotics are used to improve patient outcomes while reducing antibiotic resistance and adverse events, guided by evidence-based protocols and ongoing surveillance. It involves a coordinated approach—often with pharmacists, clinicians, microbiologists, and infection prevention teams—to select the right drug, dose, route, and duration for each patient. By using de-escalation to a narrower-spectrum agent when possible, confirming necessity, and stopping antibiotics when they’re no longer needed, stewardship protects patients from unnecessary exposure and harm, such as antibiotic-associated diarrhea or kidney toxicity, and helps limit the spread of resistant organisms.

This concept ties directly to safety and quality in medication use because it standardizes decisions around antimicrobial therapy, employs diagnostic information to avoid unnecessary treatment, and uses metrics to monitor outcomes and resistance trends. The other options describe activities that aren’t antimicrobial stewardship: increasing antibiotic use to prevent infections would worsen resistance; limiting injections isn’t the focus; and a system for lab test ordering touches on diagnostics more than antibiotic management.